In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom ...Middle East

Medscape - News
In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes. Medscape Medical News

Hence then, the article about in two analyses maestro nafld 1 trial shows safety of resmetirom was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News